5714-09-0

Basic information

• Product Name: Ethyl cartrizoate
• Synonyms: Ethyl cartrizoate;(2-ethoxy-2-oxo-ethyl) 3,5-diacetamido-2,4,6-triiodo-benzoate;(2-ethoxy-2-oxoethyl) 3,5-diacetamido-2,4,6-triiodobenzoate;3,5-diacetamido-2,4,6-triiodo-benzoic acid (2-ethoxy-2-keto-ethyl) ester
• CAS NO: 5714-09-0
• Molecular Formula: C15H15I3N2O6
• Molecular Weight: 699.992
• Mol File: 5714-09-0.mol
• Article Data: 4

Chemical Properties

• Melting Point: 269.5-270.5 °C (decomp)
• Boiling Point: 683.8°C at 760 mmHg
• Flash Point: 367.3°C
• Appearance: /
• Density: 2.238g/cm³
• Vapor Pressure: 1.5E-18mmHg at 25°C
• Refractive Index: 1.7
• PKA: 11.61±0.70(Predicted)
• CAS DataBase Reference: Ethyl cartrizoate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl cartrizoate(5714-09-0)
• EPA Substance Registry System: Ethyl cartrizoate(5714-09-0)

Safety Data

• Hazardous Substances Data: 5714-09-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C15H15I3N2O6/c1-4-25-8(23)5-26-15(24)9-10(16)13(19-6(2)21)12(18)14(11(9)17)20-7(3)22/h4-5H2,1-3H3,(H,19,21)(H,20,22)

Upstream product

• 737-31-5 sodium diatrizoate 
• 105-39-5 chloroacetic acid ethyl ester 

Relevant articles and documents

Embolus therapy using insoluble microparticles or vesicles containing contrast agents

The invention provides a method of embolus therapy comprising administering into the vasculature of a perfused zone of tissue in a human or non-human animal subject a composition comprising particles of a size or formulation selected to generate emboli at

X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays

Disclosed are x-ray contrast compositions for oral or retrograde examination of the gastrointestinal tract comprising a crystalline organic constrast agent in combination with a pharmaceutically acceptable clay in a pharmaceutically acceptable carrier; and methods for their use in diagnostic radiology of the gastrointestinal tract.